Aim Bulletin

Novacyt flags improved second-half performance

By Josh White

Date: Wednesday 22 Oct 2025

(Sharecast News) - Novacyt said on Wednesday that it expects improved second-half performance in 2025, as it outlined a new growth strategy focused on accelerating product development, achieving sustained double-digit revenue growth, and returning to EBITDA profitability.
The AIM-traded, Paris- and Manchester-based molecular diagnostics group said revenue in the second half...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page